Review: Comparing drug treatments in epilepsy
The great majority of randomised controlled trials (RCTs) that compare antiepileptic drugs are industry sponsored and have the objective of obtaining a monotherapy license for a drug. Such trials do not inform everyday clinical practice as they tend to be too short and to depart from clinical practi...
Main Authors: | David Chadwick, Arif Shukralla, Tony Marson |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2009-05-01
|
Series: | Therapeutic Advances in Neurological Disorders |
Online Access: | https://doi.org/10.1177/1756285609102327 |
Similar Items
-
Harms of antiepileptic drugs : issues in reporting and systematic reviews
by: Shukralla, A. A.
Published: (2018) -
Multiple treatment comparisons in epilepsy monotherapy trials
by: Chadwick David W, et al.
Published: (2007-11-01) -
POSSIBILITIES OF APPLICATION OF NOOTROPIC DRUGS IN TREATMENT OF EPILEPSY (LITERATURE REVIEW)
by: O. L. Badalyan, et al.
Published: (2016-05-01) -
Comparative effectiveness of antiepileptic drugs in juvenile myoclonic epilepsy
by: Katri Silvennoinen, et al.
Published: (2019-09-01) -
Refractory epilepsy and nonadherence to drug treatment
by: Oliver Henning, et al.
Published: (2019-12-01)